A carregar...
Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin
Interferon (IFN) and ribavirin (RBV) combination therapy was previously the standard of care for treatment of hepatitis C virus (HCV) genotype 2 infection. But, it often induced hemolytic anemia. In 2014, sofosbuvir (SOF) was approved for the treatment of chronic HCV genotype 2 in Japan. SOF/RBV the...
Na minha lista:
| Publicado no: | Case Reports Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5742439/ https://ncbi.nlm.nih.gov/pubmed/29375917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8793895 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|